Plasmodium falciparum triose-phosphate isomerase, a homodimeric enzyme, contains four cysteine residues at positions 13, 126, 196, and 217 per subunit. Among these, Cys-13 is present at the dimer interface and is replaced by methionine in the corresponding human enzyme. We have investigated the effect of sulfhydryl labeling on the parasite enzyme, with a view toward developing selective covalent inhibitors by targeting the interface cysteine residue. Differential labeling of the cysteine residues by iodoacetic acid and iodoacetamide has been followed by electrospray ionization mass spectrometry and positions of the labels determined by analysis of tryptic fragments. The rates of labeling follows the order Cys-196 > Cys-13 > > Cys-217/ Cys-126, which correlates well with surface accessibility calculations based on the enzyme crystal structure. Iodoacetic acid labeling leads to a soluble, largely inactive enzyme, whereas IAM labeling leads to precipitation. Carboxyl methylation of Cys-13 results in formation of monomeric species detectable by gel filtration. Studies with an engineered C13D mutant permitted elucidation of the effects of introducing a negative charge at the interface. The C13D mutant exhibits a reduced stability to denaturants and 7-fold reduction in the enzymatic activity even under the concentrations in which dimeric species are observed.The search for new therapeutic agents active against various pathogens has led to the development of inhibitors targeted to inactivate key parasitic enzymes (1-6). These approaches have led to targeting the enzymes present typically in the pathogen only (7) or selectively targeting the pathogen enzyme, if the homologous form exists in the host (8). Two distinct approaches to inactivate target enzymes may be considered. First, the design of inhibitors that compete for the active site, and second, the design of molecules that target subunit interfaces in multimeric proteins and interfere with protein assembly. In the case of many key enzymes the high degree of conservation of the active site in both host and parasite enzymes renders selective targeting difficult. Interfaces may show greater structural variations permitting a distinction between the host and the pathogen enzymes. Two distinct strategies usually considered for disrupting intersubunit contacts in proteins are: (i) the design of synthetic peptides and peptidomimetics of interface segments, which may interfere with the subunit association (9 -11), and (ii) covalent chemical modification of reactive residues at the interface, which may cause disruption of the oligomeric state of the protein (12)(13)(14). In this regard, glycolytic enzymes are attractive targets, primarily because of their central role in energy production in the parasites (15-18).Triose-phosphate isomerase (TIM) 1 is an important glycolytic enzyme that catalyzes the interconversion of glyceraldehyde 3-phosphate to dihydroxyacetone phosphate (19,20). From the available knowledge of the structure of TIMs it is seen that the enzyme is a homo...